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Evidence suggests that monitoring and appraising symptoms can result in increased
engagement in medical help-seeking, improved patient-doctor communication, and
reductions in symptom prevalence and severity. To date, no systematic reviews
have investigated whether symptom monitoring could be a useful intervention
for menopausal women. This review explored whether symptom monitoring could
improve menopausal symptoms and facilitate health-related behaviours. Results
suggested that symptom monitoring was related to improvements in menopausal
symptoms, patient-doctor communication and medical decision-making, heightened
health awareness, and stronger engagement in setting treatment goals. Meta-analyses
indicated large effects for the prolonged use of symptom diaries on hot flush frequencies.
Between April 2019 and April 2021, PsychInfo, EMBASE, MEDLINE, CINAHL, Cochrane,
ProQuest, PsychArticles, Scopus, and Web of Science were searched. Eighteen
studies met the eligibility criteria and contributed data from 1,718 participants. Included
studies quantitatively or qualitatively measured the impact of symptom monitoring
on menopausal populations and symptoms. Research was narratively synthesised
using thematic methods, 3 studies were examined via meta-analysis. Key themes
suggest that symptom monitoring is related to improvements in menopausal symptoms,
improved patient-doctor communication and medical decision-making, increased health
awareness, and stronger engagement in goal-setting behaviours. Meta-analysis results
indicated large effects for the prolonged use of symptom diaries on hot flush frequency:
0.73 [0.57, 0.90]. This review is limited due to the low number of studies eligible for
inclusion, many of which lacked methodological quality. These results indicate that
symptom monitoring has potential as an effective health intervention for women with
menopausal symptoms. This intervention may be beneficial within healthcare settings, in
order to improve patient-doctor relations and adherence to treatment regimes. However,
findings are preliminary and quality assessments suggest high risk of bias. Thus, further
research is needed to support these promising outcomes.
Systematic Review Registration Number: https://www.crd.york.ac.uk/prospero/
display_record.php?, PROSPERO, identifier: CRD42019146270.
Keywords: symptommonitoring, menopause, midlife, menopausal symptoms, MRC framework, health behaviour,
e-health, women’s health
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INTRODUCTION
The menopause is diagnosed when over 12 months has passed
since a woman last menstruated (1). Although cessation of
menses is positively anticipated by some, the menopause, and the
years prior, the perimenopause, can encompass a vast array of
symptoms which can negatively impact quality of life (1, 2). These
symptoms can be physiological in nature, including hot flushes
and joint aches, whereas others impact psychological wellbeing,
such as anxiety and low mood (1, 2).
Symptom monitoring has benefited numerous clinical
populations, including patients with fibromyalgia, clinical
depression, and cancer (3–5). Symptom monitoring involves
recording symptoms using diaries, symptom questionnaires,
or electronic health (e-health) instruments, including mobile
apps or online symptom trackers; this can take place across
time, or retrospectively at one or more given time points
(6). Notable outcomes have included increased likelihood of
accessing healthcare, heightened survival rates, and reductions
in symptom prevalence and severity (3–5, 7, 8).
Despite broader literature demonstrating beneficial effects,
symptom monitoring has not been formally evaluated
as an intervention (3–5, 7, 8). According to the Medical
Research Council’s (MRC) framework for developing complex
interventions, existing evidence for an intervention should
ideally be collated into a systematic review to understand
whether it is likely to be effective, whether it can be implemented
into a research setting, and whether it can be widely implemented
if the results are favourable (9). Should a review find evidence
that an intervention is related to beneficial outcomes, the next
evaluative phase should include an exploratory trial to measure
the observed effects (9).
Thus, this review was designed according to three objectives:
to assess whether symptom monitoring improves health
outcomes relating to the menopause, e.g., changes in severity
and reporting frequency of symptoms, or greater adherence to
health-related behaviours; to evaluate mechanisms explaining
why symptom monitoring influences health outcomes related to
the menopause, e.g., whether it leads to greater health awareness
or medical help-seeking; and, to categorise and compare the
effects of different methods of symptom monitoring in order to
inform best practise and intervention development.
The studies included in this review reported quantitative
or qualitative data on the independent effects of symptom
monitoring on menopausal symptoms, either as the intervention
of interest or as a comparison or control intervention. Key
outcomes included variances in symptom incidence or severity,
and changes in health-related behaviour.
METHODOLOGY
The methods used in this review are briefly summarised here,
however it is recommended that the PROSPERO protocol
be referred to for further details: registration number:
CRD42019146270, available from: https://www.crd.york.
ac.uk/prospero/display_record.php?ID=CRD42019146270.
This review was developed in accordance with the PRISMA
guidelines, and the Cochrane handbook for systematic reviews
of interventions was consulted and the guidance followed (10).
Search Strategy
Between April 2019 and August 2019, the following databases
were searched PsycINFO, EMBASE, MEDLINE, CINAHL,
Cochrane Library, ProQuest, PsycARTICLES, Scopus, and Web
of Science. Updated searches took place in August 2020 and April
2021. Additional records were identified through forward and
backward citation searches. Filters were used to focus the searches
on English-language, female, adult-human participants. Date and
geographical restrictions were not applied. Included studies had
quantitatively or qualitatively assessed the independent effects of
symptom monitoring on menopausal health outcomes.
Titles and abstracts were screened according to three
preliminary criteria:
1. Participants included human adults, either mixed-gender or
female-only. Mixed-gender research had to provide isolated
data by gender.
2. The study collected data on the independent influence of
symptom monitoring on health outcomes, either as the
intervention of interest or as a comparison or control
intervention, excluding researchwhich instructed participants
to monitor their symptoms in conjunction with a separate
intervention.
3. The study explored common menopausal symptoms,
excluding conditions which could impair an individual’s
ability to monitor their symptoms accurately, or could lead
to fatality, hospitalisation, or were developed as a result
of trauma.
Full-text reports which appeared to meet the outlined criteria
were screened independently by two authors. Prior to screening,
authors engaged in a calibration process in order to enhance
inter-reviewer consistency by screening 25 randomly selected
studies. A Kappa statistic of: κ =0.757, ρ = 0.001 quantified
agreement, indicating substantial inter-reviewer consistency
(11). Any disagreements were discussed by authors. A PRISMA
flowchart was produced to display the process of study selection,
as well as reasons for exclusion (see Figure 1).
Quality Assessment
For quantitative research, the National Institute for Health and
Care Excellence (12) developed a checklist based around the
Graphical Appraisal Tool for Epidemiological studies [GATE;
(13)]. NICE (12) appropriated this checklist for evaluating health
intervention studies. This checklist was deemed suitable for this
review as it can be used to appraise the internal and external
validity of various research designs.
An appraisal tool for qualitative research was used to assess
studies with these characteristics (14). This checklist is based
around characteristics of qualitative research which may affect a
study’s internal validity, i.e. whether the links between the data,
interpretations, and conclusions are clearly defined (14).
Both checklists were amended according to each study
under review; in cases where randomisation did not occur
(i.e. in observational studies) judgements were made based on
Frontiers in Global Women’s Health | www.frontiersin.org 2 December 2021 | Volume 2 | Article 757706
Andrews et al. Symptom Monitoring Benefits Menopause
FIGURE 1 | PRISMA flowchart of study selection process.
whether confounding variables may have influenced findings.
Thismethod has been implemented into the Cochrane risk of bias
tool, hence why it was deemed appropriate (10).
Data Analysis
A thematic synthesis provided a means of combining qualitative
and quantitative information in a succinct manner. This
meant that findings from all included studies could be
simultaneously evaluated and compared. Key themes were
identified by summarising the extracted results of each study,
with contributions being made by 2 authors.
RevMan 5.3 software was used to compute a meta-analysis of
comparable studies which used continuous data. Three studies
described comparable study designs and symptom monitoring
methods, pre-treatment and post-treatment data were combined,
and the standardised mean difference and 95% confidence
intervals (CIs) were computed. A random-effects model was used
to compensate for variations within the selected studies. The
classification of effect sizes was determined from Cohen’s (15)
conventional values of effect size which indicate: 0.20 = small
effect size, 0.40=medium effect size, and 0.60= large effect size.
Significance was set at ρ < 0.05.
Heterogeneity was tested using the I² value. The interpretation
of the observed I² value was determined by The Cochrane
Handbook of Systematic Reviews guidance which indicated
that I² <30% was considered mild heterogeneity, I² >30% as
moderate heterogeneity, I² >50% as substantial heterogeneity
and I² >75% as considerable heterogeneity (16).
Due to differences in menopausal symptoms and symptom
monitoring methods, populations and interventions varied,
therefore results were predominantly synthesised narratively.
A meta-analysis was conducted on three studies which had




Searches returned 18 studies which met the eligibility criteria and
contributed data from 1,718 participants, see Figure 1 to view
summary of study selection process.
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Two studies involved the Women’s Health Assessment Tool
(WHAT), a symptom questionnaire relevant to midlife women
(17, 18). Two studies included the Menopause Rating Scale
(MRS), a questionnaire developed to evaluate menopausal
symptom frequency, severity, and change (19, 20). Two
studies explored The Computerised Symptom Capture Tool
for Menopause [C-SCAT-M; (21, 22)]. The C-SCAT-M is a
mobile app which features 54 menopausal symptoms, which
were originally identified via the Seattle Women’s Midlife Health
Study (SWMHS). One study qualitatively explored the effects
of daily self-weighing on perimenopausal weight changes (23).
One study explored the MenoScores Questionnaire, the primary
outcome was the hot flush scale (24). Four studies provided
data on the effects of symptom diary use on perimenopausal
symptoms, menopause-related headaches, sexual dysfunction,
and incontinence (25–28). Six randomised controlled trails
(RCTs) provided data on symptom-diary use and hot flush
frequency (29–34). Three RCTs were evaluated via meta-analysis
(30–32). See Table 1 to view a full summary of the characteristics
of the included studies.
Quality Assessment
Few studies were judged to have adequate validity, with all
but 4 being considered unsatisfactory (30–33). See Table 2




Five themes were identified, one was related to physiological
changes following adherence to symptom monitoring and
encompassed variations in symptom frequency and severity
regarding hot flushes, urinary incontinence, migraines, sexual
dysfunction, and depression; the other four themes encompassed
health-related behavioural changes and included improvements
in patient-doctor communication, shared decision-making,
health and symptom awareness, and goal setting.
Physiological Changes
Hot Flushes
Reductions in hot flush frequency were present among studies
which involved the use of symptom diaries (24, 30–33). Four
randomised trials included before and after data on the effects of
symptom diaries on vasomotor symptoms (VMS) and reported
significant reductions in hot flush frequency scores (30–33).
Diary studies with smaller sample sizes also reported reductions
in VMS, although these findings were non-significant (29, 34).
Urinary Incontinence
Huang et al. (26) used voiding diaries to research symptom
change and frequency among 19 menopausal women with
urinary incontinence partaking in a yoga therapy intervention.
All participants kept 7-day voiding diaries where they recorded
each time they leaked urine. After 6 weeks, total incontinence
frequency had reduced by 13% in the control group which used
the voiding diary alone.
Migraines
Stensland and Malterud (28) described a perimenopausal
patient presenting with worsening migraine and muscle pain.
This patient was advised to compile an illness diary for 4
weeks, detailing the strength of her headache, its localisation,
accompanying symptoms, situations where it had occurred, and
medications used (28). After 4 weeks of diary use the patient
reported using half as much medication as she had the month
prior (28). At four-month follow-up the patient stated that her
symptoms had improved even more so, and attributed these
improvements to her becoming more aware and reflective of her
health through the symptom-diary (28).
Sexual Functioning and Depression
Muin et al. (25) studied 30 menopausal participants diagnosed
with sexual dysfunction, who were asked to keep a sexual
diary for 4 weeks. Sixty percent of participants reported
subjective improvements in sex life and sexual communication




Two studies explored the WHAT menopause symptom
questionnaire among menopausal patients attending a well
woman clinic (17, 18). These studies reported that the WHAT
had improved patient-doctor communication from both
the clinicians’ and patients’ perspectives, which led to a rise
in the number of diagnoses made, especially for sensitive
conditions including vaginal dryness, sexual dysfunction and
depression (17, 18).
Ismail and colleagues (21) evaluated the C-SCAT-M app,
which enables users to appraise their menopause symptoms and
generate a report. Participants were asked to voice their thoughts
and experiences whilst completing the app, and many requested
a copy of their symptom report to share with their physician,
commenting that it would be a useful communication aid (21).
Shared Decision-Making
Two studies evaluating the MRS found it improved patients’
efficacy in making medical treatment decisions (19, 20).
Hale et al. (27) employed symptom-diaries to explore whether
menopausal symptoms were related to the menstrual cycle.
Diaries showed premenstrual increases in breast tenderness
and VMS, therefore authors hypothesised that symptom diaries
could help women identify when cyclical HRT or non-hormonal
treatments might be more beneficial than continuous HRT (27).
Health Symptom Awareness
During Zangger et al.’s (20) study, one participant stated that
being able to see her symptoms visually represented on the
MRS had enabled her to recognise that they were connected. In
Ismail and colleagues (21) study, participants found solutions
to their symptoms as they completed the C-SCAT-M app. The
researchers proposed that heightened symptom awareness had
prompted participants to reflect upon strategies to alleviate
their symptoms.















































Details of administration of symptom
monitoring
Data relating to the effects of symptom
monitoring


















Participants were surveyed once to
determine a cut-off score on the MRS to
indicate a need for treatment with HRT.
Each symptom-specific item on the MRS
was accompanied with another item
which asked participants to indicate
whether they thought that particular
symptom required treatment.
After completing the MRS women were able to
recognise when they needed medical help for
their symptoms, supported by the items asking
women if particular symptoms required
treatment.






Hot flushes Postmenopausal (55.3) Daily diaries recorded hot
flush frequency.
Daily hot flush diaries were adhered to by
both groups for 2 weeks at baseline, and
then daily for up to 15 weeks.
From baseline to 15 weeks there was a
non-significant 2% reduction in hot flushes in
the usual activity control group which adhered
to the symptom diary only. However, there was
a significant 43.6% decrease in hot flushes in
the resistance training group.







Hot flushes Postmenopausal (53.8) Diary recorded frequency
and severity of hot flushes
and sleep duration.
Daily diaries were administered to both
participant groups for 2 weeks at baseline,
and for 1 week at weeks 4, 8 and 12.
In both groups there were similar reductions in
daily hot flush frequency and intensity, and
small increases in hours of sleep per night.
Borud et al. (33)
Norway
6- and 12- month






Hot flushes Postmenopausal (53.8) Diary recorded daily
frequency and severity of
hot flushes and sleep
duration.
Daily diaries were administered to both
participant groups at weeks 4, 8, and 12.
During the 6- and 12- month follow-ups,
identical recordings were performed.
From baseline to six months, there were similar
reductions in daily hot flush frequency and










Electronic hot flush diaries
for ≥ 24 h to ≤ 7 days (time
determined by participant
choice).
Hot flush frequency, severity, and bother
(vasomotor symptoms), were
prospectively recorded in diaries in real
time by both participant groups at 2
weeks baseline and at 8 and 16 weeks
Paced respiration was not significantly more
efficacious than breathing control or usual care
for producing a 50 % reduction in hot flushes.
Percentages achieving 50 % reduction in hot
flashes from baseline to 16 weeks were: 38 %
intervention, 29 % breathing control, and 22 %
usual care control.
Hale et al. (27)
Australia
Observational (24) Breast tenderness,
vasomotor symptoms,
period changes
Perimenopausal (47) Daily perimenopause diary Participants used the perimenopause diary
to record hot flush frequency and severity,
breast tenderness, and menstruation
across 4 menstrual cycles each (data on
98 cycles was collected in total).
Diaries show premenstrual increases in breast
tenderness and VMS. Because hot flushes
were related to menstrual cycles, the study
hypothesised that these women may not
benefit as much from hormone therapy,
therefore diaries could help women make










































































































Details of administration of symptom
monitoring
Data relating to the effects of symptom
monitoring











7-day voiding diaries Participants recorded each time they
leaked urine and classified their leakage
episodes as stress type (associated with
coughing, sneezing, lifting, or physical
activity), urgency-type (associated with a
strong need or urge to void), or other-type
(not associated with physical activity or
with an urge to void).
The mean frequency of incontinence
decreased by an average of 66% from baseline
in the yoga therapy group and 13% in the
control group. Stress incontinence frequency
decreased by an average of 85% in the yoga
therapy group, compared to a mean increase
of 25% for the control group.










and intensity of hot flushes
Each subject completed a daily hot flush
symptom diary form. Participants were
instructed to record the frequency and
intensity of daily hot flash symptoms using
a Likert-type scale with values from 1 to 7,
with 1 being mild and 7 being extremely
severe.
All the groups had a decrease in flash
frequency, but these did not reach statistical
significance. The Relaxation group
demonstrated a significant decrease in hot
flush intensity. The Reading group
demonstrated a small non-significant decrease
while the control group demonstrated a small
non-significant increase.


















While completing the C-SCAT-M app
women were asked to “think aloud”, and
these thoughts were recorded and
transcribed. Women completed the app
using an iPad and they identified symptom
clusters by drawing links between their
current symptoms.
Most women stated that the final diagrams
were very/extremely accurate depictions of
their symptom clusters (77%). Participants
were asked about their feelings in response to
being requested to think about their symptoms
while completing the app. Women said they felt
“fine,” “surprised,” “sad,” “annoyed,”
“depressed,” and “more aware about their
symptoms.” Other women even reported
finding solutions to their symptoms as they
completed the app.




















MenoScores questionnaire All participants completed the MSQ after
receiving it by email in study weeks 0, 3, 6,
8, 11 and 26.
The control group showed a trend of
improvement, in particular in the hot flush
scale, which may be explained by a regression
to the mean. The acupuncture treatment
reduced the hot flush, day-and-night sweats,
general sweating, sleep problems, emotional
symptoms, physical symptoms, and skin and
hair scales after 5 weekly treatments. The











































































































Details of administration of symptom
monitoring
Data relating to the effects of symptom
monitoring





Low mood and sexual
dysfunction
Peri/postmenopausal (53) Sexual activity record
(completed by participants
only) and a sexual diary
(completed by participants
and their partners)
The sexual activity record and the sexual
diary were administered for 4 weeks. The
sexual activity record was used to
document the time and date of sexual
events. Participants and their partners
recorded their current sexual satisfaction
and/or fantasies, as well as anything else
that might have interfered with their most
recent sexual activity (i.e. partner’s
absence or illness) using the sexual diary.
A subjective improvement in communication of
sexual problems was reported by 60% of
participants; no participants reported any
worsening of communication. This finding was
not paralleled by objective measures taken
using the Female Sexual Function Index (FSFI)
and the Female Sexual Distress Scale (FSDS),
neither of which had found statistically
significant improvements. Significant
improvements were found using the Hamilton
Depression Scale (HDS), suggesting that
participants had lower levels of depression after
using the sexual diary.


















The WHAT was administered through
MyChart, an online patient portal system.
One week prior to their annual
well-woman visit participants were asked
to complete the online WHAT
questionnaire. After this visit patients were
surveyed about their perceptions of using
the WHAT questionnaire.
Most patients felt more prepared for their
annual visit (69.7%), improvements in
patient-doctor communication (69.8%) and that
quality of care improved (68.4%) while clinicians
reported streamlined patient visits and
improved communication with patients. Most
(71.1%) women “agreed” or “strongly agreed”
that they would use the questionnaire again.


















The WHAT was administered through
MyChart, an online patient portal system.
One week prior to their annual well-woman
visit participants were asked to complete
the online WHAT questionnaire.
There were 31 new diagnoses made during the
well-woman visit, representing a 72.2% change
in the diagnoses rate compared with the visits
from 12 months prior (previous 12-month
diagnoses: n = 18). Hot flushes had the
greatest number of new diagnoses during the
well-woman visit, closely followed by






Headache Menopausal (48) Illness diary: Strength of
headache, localisation,
accompanying symptoms,
situations where it occurred
and medication.
The participant made notes in the diary for
1 month. Introduced to diary during first
meeting and reviewed 4 weeks later
(based on written material and
conversation) and 4 months later when a
clinical supervisor participated
After 1 month the patient had taken less
medication and had fewer headaches. After 4
months she had not consulted a GP since her
last appointment and had even fewer
headaches than before. When asked about
writing things down she said she had become
more conscious, more reflective, and had more
of a hold on self. She also felt calmer and had











































































































Details of administration of symptom
monitoring
Data relating to the effects of symptom
monitoring








Peri/ postmenopausal (55) Daily diaries recorded hot
flush frequency and bother.
Hot flush frequency and bother were
recorded for 2 weeks at baseline and for 1
week at weeks 6 and 12. How flush bother
was rated each day on a scale of 1-4
12 weeks of moderate intensity aerobic
exercise did not reduce frequency or bother of
VMS more than usual activity in initially
sedentary women. At the end of week 12,
changes in VMS frequency in the exercise
group (mean change of −2.4/day, 95% CI
−3.0, −1.7) and VMS bother (mean change of
−0.5 on a 4 point scale, 95% CI −0.6, −0.4)
were not significantly different from those in the
control group (−2.6 VMS/ day, 95% CI −3.2,
−2.0, p=0.43; −0.5 points, 95% CI −0.6,
−0.4, p=0.75).
Su et al. (23)
Taiwan
Qualitative (18) Weight gain Perimenopausal (51.5) Daily self-weighing Not administered during study, some
participants discussed monitoring their
weight daily during interviews
Several women measured their weight daily. If
they had gained weight they reviewed all the
possible reasons. Key themes derived from
interviews included ‘enjoying my new life,’
‘mastering self-monitoring of my health’ and
‘learning to communicate with the body’.
Women enjoyed and mastered self-monitoring
of their health, learned to communicate with
their body and integrated new changes into
their life: “I measure my weight every day to
serve as a warning to myself. I often ask
myself: did I eat too much recently? Otherwise,
why did my weight increase? I think the body
becomes healthier, I am enjoying life now.”




















While completing the C-SCAT-M app
women were asked to “think aloud”, and
these thoughts were recorded and
transcribed. Women completed the app
using an iPad and they identified symptom
clusters by drawing links between their
current symptoms.
Most women (77%) stated that the final
diagrams were very/extremely accurate in
depicting their symptoms and their connexions.
Women reported between 1 and 22 symptoms
(median 11). Hot flushes, waking up during the
night, night sweats, and early morning
awakening were the most commonly reported
symptoms. Women rated hot flushes as their
most bothersome symptom, followed by
waking up during the night and fatigue. They
believed that hot flushes caused several
symptoms, especially sleep disruption, and
most could describe the time order of their
symptoms. Women reported clusters
consisting of 2 to 18 symptoms. Women also
named each cluster based on their response to
their symptoms (“really annoying”), the time of
occurrence (“night problem”), and symptoms in










































































































Details of administration of symptom
monitoring
Data relating to the effects of symptom
monitoring
clusters to menopause and life demands. Many
women requested a copy of their final
symptom cluster diagram to discuss it with
their health care providers.
Zangger et al. (20)
Switzerland





Peri/ postmenopausal (46) Menopause Rating Scale
(MRS-II)
The patients filled in the MRS-II
questionnaire prior to consultation with
their physician. During the consultations,
physicians transferred the patient’s MRS
responses into the digital ICF profile and
discussed the goals to be achieved during
therapy. The ICF profile organised the
patient’s MRS responses to depict their
functional status. The tool also identified
areas of poor functional capabilities related
to their menopausal symptoms, and
produced long, middle, and short-term
goals for functional improvement.
From patients’ perspective, filling in the ICF
Categorical Profile helped to structure their
goals but did not improve the overview of
symptoms. Participants felt that filling in the ICF
did not help identify their problems as they
were already clear before. However, it helped
them understand that their symptoms were
connected. While filling in the ICF Profile,
participants found thinking about their goals
helped them handle their symptoms better. The
participants stated that being able to visualise
their symptoms had helped narrow them down
and to see their limitations in a different light. All
patients agreed that it was helpful to think
about the goals they wanted to achieve and
define them precisely as well as to define
short-, middle- and long-term goals. Also, for
all three patients the ICF Categorical Profile did
not much change the decision process when
discussing the treatment options. Though one
patient stated that the visualisation helped to
get an overview over the priorities of the
treatment, she also said that the physician’s
opinion was most important for her to decide
which treatment was best. The other two
patients said that the priorities for treating their
symptoms had been clear before, yet the ICF
Categorical Profile had helped them to decide





























































































TABLE 2 | Quality assessment summary.
References Study design NICE quality
checklist
Internal validity External validity Overall
assessment
Notes
Ismail et al. (21) Qualitative Qualitative checklist - - - • No justification for not triangulating data.
• Small sample size.
• Study design may have been vulnerable to demand characteristics/ desirability
bias.
• Did not describe role of researchers, nor methods of analysing the data.
Silvestrin et al. (17) Observational/ cross
sectional
Quantitative checklist - - - • Study design may have been vulnerable to demand characteristics/ desirability
bias
• Recruited from 3 clinics.
• Sample was not ethnically diverse.
• Did not use a control group to assess effect sizes.
Silvestrin et al. (18) Observational/ cross
sectional
Quantitative checklist - - - • Used before and after data from the same participants instead of a control group
• Recruited from 3 clinics
• Sample was not ethnically diverse.
Stensland and
Malterud (28)
Case-study Qualitative checklist - - - • Did not present data systematically.
• Did not involve methods of triangulation
• Did not discuss in detail reduction in medication use/ symptoms.
Woods et al. (22) Qualitative Quantitative checklist - - - • Study design may have been vulnerable to demand characteristics/ desirability
bias
• Objectives and a design were not clearly defined
• Lack of triangulation was not justified but would have been useful to
minimise bias.
Zangger et al. (20) Qualitative Qualitative checklist - - - • Number of researchers involved in transcript analysis was unclear
• The interview setting/ context was unclear.
• Results were not systematically reported.
Irvin et al. (34) RCT Quantitative checklist - - - • A small participant sample was used, therefore the study was not sufficiently
powered.
• Lack of blinding and allocation concealment.
• Intervention exposure time may have been too long, many participants dropped
out as they found 7 weeks of symptom charting too intrusive.
• Did not include standard deviations in outcome data.
Blumel et al. (19) Observational/ cross
sectional
Quantitative checklist + - - • Participants were recruited from a single clinic.
• Used highly subjective measures rather than diagnostic tests or
filled prescriptions.
Muin et al. (25) Non-randomised trial Quantitative checklist + - - • Participants were treatment seeking so may not appropriately represent women
with sexual dysfunction.
• Used a small participant sample- therefore may have been underpowered to
detect significant effects.
• Did not include randomisation which would have shown a more rigorous effect































































































TABLE 2 | Continued
References Study design NICE quality
checklist
Internal validity External validity Overall
assessment
Notes
Lund et al. (24) RCT Quantitative checklist + - - • The intervention group had regular meetings with GPs. This may have increased
the likelihood of experimenter bias or demand characteristics/ social desirability
bias.
• Participants were recruited using adverts in acupuncture authorities, which
meant these participants were self-selecting and likely to be inclined toward
the intervention (acupuncture).
• It is not clear whether reductions in hot flushes in the control group reached
statistical significance.
Su et al. (23) Qualitative Qualitative checklist + - + • No methods of triangulation described.
Berin et al. (29) RCT Quantitative checklist + - + • The intervention group had regular meetings with physiotherapists. This may
have increased the likelihood of experimenter bias.
• Exposure time may have been too long, as many control participants did not
consistently complete symptom diaries over 15 weeks.
• Most incomplete diaries belonged to the control group (10/14), which could
have increased the risk of bias in the results.
Huang et al. (26) RCT Quantitative checklist + - + • Participants were not blinded to allocation, which could have affected results.
• A small participant sample was used, therefore the study was not well powered.
• There were varying characteristics between groups, but it is unclear whether
these were adjusted for.
Hale et al. (27) Observational Quantitative checklist ++ - + • Long list of symptoms to monitor each day, may have increased likelihood of
retrospective recording and data inaccuracies.
• Small sample size.
Carpenter et al. (31) RCT Quantitative checklist + + + • Participants were offered a cash incentive, which could have increased
response bias.
• Non-blinded staff carried out quality-check visits to see if the intervention was
being adhered to correctly, this could have led to experimenter bias, demand
characterises, or desirability bias.
• Wait-list control could have been more appropriate to conceal allocation.
Sternfeld et al. (30) RCT Quantitative checklist ++ + + • Does not discuss whether the symptom diary or participation may have elicited
the reductions in symptoms across all groups.
• Exercise group spent time with a trained exercise practitioner which could
have led to social desirability bias.
Borud et al. (32) RCT Quantitative checklist ++ + + • It was not possible to blind participants to exposure.
• Participants applied to the study via adverts, which could indicate self-selection
bias.
• Participants had a positive attitude toward the key intervention (acupuncture),
therefore contamination may have been more likely.
Borud et al. (33) RCT Quantitative checklist ++ + + • A 6 and 12 month follow up of the above.
• High risk of exposure to factors which could have affected the results (i.e. HRT
use, over the counter medication, exercise or behavioural interventions).
Key.
++ = All or most of the checklist criteria have been fulfilled, where they have not been fulfilled the conclusions are very unlikely to alter.
+ = Some of the checklist criteria have been fulfilled, where they have not been fulfilled, or not adequately described, the conclusions are unlikely to alter.
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Su et al. (23) evaluated the weight loss experiences of 18
obese perimenopausal women who had been diagnosed with
metabolic syndrome. Findings demonstrated that awareness of
weight gain was a factor that motivated perimenopausal women
to change their lifestyle habits (23). Participants expressed that
they had become more aware of their health via daily self-
weighing, which made them feel better able to “communicate
with their body’s voice” (23).
Goal Setting
Another finding to emerge from Zangger et al.’s (20) study was
related to goal setting. After completing the MRS, women were
able to restructure their symptom scores into short-, middle,
and long-term health goals. Another study conducted by Woods
and colleagues (22) evaluated the C-SCAT-M. This research
focused on the app’s ability to allow women to communicate their
heuristics related to menopausal symptom attributions (22). By
using the C-SCAT-M, women reported their symptoms, grouped
them into clusters, specified the order of occurrence, gave the
clusters meaningful names, and identified relationships between
symptoms. The authors speculated that by appraising, naming,
prioritising, and grouping their symptoms, participants gleaned
a greater understanding of what they were hoping to achieve in
terms of treatment.
Comparing Symptom Monitoring Methods
Monitoring symptoms across time appeared to be useful for
reducing symptom frequencies, as well as medication usage, and
this effect may be explained by heightened health and symptom
awareness (24–26, 28–34). Patient-doctor communication was
facilitated by tools which allowed users to define the totality
of their symptoms from an exhaustive inventory (17, 18, 21).
Medical decision-making was facilitated by utilising symptom
appraisal tools in conjunction with items assessing medication
need, or digital ICF profiles, thus suggesting that input from
medical systems is vital for unlocking the tool’s decision-
making capabilities (19, 20). Medical decision-making may also
be improved by menstrual diaries, as they can allow patients
and practitioners to understand whether VMS are related
to the menstrual cycle or menopause (27). An illness diary,
symptom appraisal tools, and daily self-weighing were related
to improvements in health and symptom awareness, and this
increased awareness was related to symptom improvements and
changes in health-related behaviours (20, 21, 23, 28). Finally,
symptom appraisal tools which allowed the user to compare
their symptoms and corresponding severities supported setting
treatment goals (20, 22).
Meta-Analysis
Included Studies
Three RCTs were deemed appropriate for evaluation via
quantitative synthesis. These studies included continuous data
measuring the independent effects of prolonged symptom diary
use on VMS frequency (30–32). Using a random effects model,
the standardised mean difference and statistical heterogeneity
with Chi² and I² figures were calculated.
Excluded Studies
Three other studies measured the independent effects of
prolonged symptom diary use on VMS (29, 33, 34). One was
excluded because it used a small participant sample (N = 11) in
the symptom diary arm and failed to provide standard deviations
for mean frequency of VMS following symptom diary use (34).
Berin et al.’s (29) study was excluded from the main meta-
analysis because a disproportionate amount of missing data was
attributed to the control group. The control group provided
before and after data from participants who had been using
VMS diaries for 15 weeks, however 35% of these participants
did not consistently complete diaries. This meant the analysis
likely underestimated reductions in VMS (29). To understand the
impact of excluding this study on the overall effect of symptom
monitoring, a meta-analysis was conducted with Berin et al.’s
(29) data included and it suggested a large effect size (0.61, 95%
CI 0.34 to 0.88) with the difference being significant in favour
of post symptom-diary use (Z = 4.45, p = 0.001). However,
heterogeneity was substantial (I²= 60%).
A third study was excluded which depicted a 6- and 12-month
follow-up of a study which is included in the present meta-
analysis (33). The later study increased the heterogeneity statistic
(I² = 78%), therefore the earlier study by Borud et al. (32) was
chosen for inclusion.
Reduction in Symptom Frequency
The three included studies involved a total of 303 participants
at baseline, and 296 participants post-intervention. Each study
reported continuous data for VMS frequencies. Two studies
included mean differences in VMS frequency following symptom
diary use therefore mean VMS frequency following symptom-
diary use was calculated by subtracting the post-intervention
mean difference from the pre-intervention mean (30, 32).
Borud et al. (32) reported mean frequency of VMS at baseline
and the standard deviation (13.1, 4.9) and mean change in
VMS frequency following symptom diary use and the standard
deviation (9.4, 3.7). Sternfeld et al. (30) reported confidence
intervals instead of standard deviations for baseline VMS
frequency (8.0 [7.3, 8.7]) and mean change in VMS frequency
following symptom diary use (−2.6 [−3.2, −2.0]), therefore
confidence intervals for baseline and post-intervention measures
were recalculated into standard deviations (4.26, 3.56). Carpenter
et al. (31) reported mean frequency of VMS and standard
deviations pre (7.31, 4.04) and post prolonged symptom-diary
use (4.76, 3.5).
The standardised mean difference for symptom frequency
suggested a large effect size (0.73, 95% CI 0.57 to 0.90) and the
difference was significant in favour of post symptom-diary use
(Z = 8.68, p = 0.001). Heterogeneity was absent (I² = 0%). See
Figure 2 to view a forest plot detailing the effects of symptom
diaries on hot flush frequency scores.
DISCUSSION
This review investigated whether symptom monitoring could
yield improvements in menopausal symptoms and health-related
behaviours. This suggests that symptommonitoring has potential
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FIGURE 2 | Forest plot showing hot flush frequency at baseline and post-symptom diary use.
as an effective intervention. Systematic searches returned 18
studies which contributed data from 1,718 participants. Methods
which allowed patients to track their symptoms across time
were related to symptom improvements and heightened health
awareness, whereas tools which enabled patients to appraise their
symptoms at any given time point enhanced health awareness,
treatment goal setting, patient-doctor communication, and
shared decision-making. A meta-analysis suggested large effects
for the prolonged use of symptom diaries on VMS frequencies:
0.73 [0.57, 0.90]. In regard to the MRC framework, these results
suggest that the effects of prolonged symptom monitoring be
further measured via an exploratory trial; and should symptom
monitoring be implemented within the wider community, it is
recommended that symptom monitoring and appraisal methods
should include an exhaustive array of symptoms and be used
in conjunction with organised health systems in order to reap
potential benefits in patient doctor communication, medical
decision-making, and treatment goal setting (9).
The key finding from this review was that tracking symptoms
could facilitate improvements (24–26, 28, 30–34). This is
supported by the meta-analysis which assessed VMS frequency
scores at baseline and after prolonged symptom diary use; results
favoured post-diary use and showed large effects for reducing
VMS (30–32). This result has been demonstrated by prior studies
which have shown symptom reductions within alternative patient
populations, suggesting that the beneficial effects of symptom
monitoring are transferable across multiple ailments (5, 7, 8).
Symptom monitoring was also associated with improvements
in health-related behaviours, including heightened awareness
(21–23, 28). Ismail et al. (21) reported that women found
solutions to their menopausal symptoms as they completed the
C-SCAT-M, suggesting that symptom appraisal had brought
the participant’s health to the forefront of their minds, which
prompted them to reflect, consider remedies, and invoke
behavioural changes (21). A similar result was reported in a
case-study whereby a patient reported reductions in medication
use and headache symptoms following use of a symptom diary;
the patient attributed these improvements to the symptom diary
heightening her awareness, which prompted her to amend her
health behaviours accordingly (28).
The MRS and the C-SCAT-M were related to treatment goal
setting (20, 22). Goal setting is a facet of Chewning and Sleath’s
(35) client-centred model of medical decision-making and
management. This model depicts how the patient and physician
could work together to carry out the following practises: identify
treatment goals, choose treatment options, monitor symptoms
and evaluate treatments, and revise treatments if problems occur.
Symptom monitoring methods could support this model,
tools such as the MRS and the C-SCAT-M can help patients
prioritise symptoms and identify the improvements they
expect to see in the future, and this process can facilitate
decision-making and patient-doctor communication. This
theory corresponds with additional themes from this review,
which found evidence that symptom monitoring could be useful
for improving patient-doctor communication and facilitating
decisions to use HRT and seek timely medical help (17–21, 27).
Limitations and Future Directions
This review is limited by the low number of studies identified for
inclusion, many of which were lacking methodological quality.
Moreover, only three studies were integrated into the meta-
analysis, meaning a funnel plot was not computed and risk
of bias could not reliably be ascertained (36). Meta-analyses
with low study inclusions are notorious for overestimating effect
sizes (37).
To the author’s knowledge, no other meta-analyses of
this type have been conducted before, therefore this review
provides a foundation for subsequent estimations of the
effects of symptom diaries in symptom reduction. Numerous
studies have given evidence that symptom monitoring
could yield symptom improvements for a number of
conditions (5, 7, 8). Therefore, future reviews should assess
prolonged symptom monitoring on alternative conditions
and symptoms.
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An unexpected observation was that authors appeared to
consider symptom monitoring as a benign “control” activity
(29–32). Only two RCTs acknowledged the symptom reductions
observed within the control groups, and neither considered
whether symptom monitoring contributed to these reductions,
despite symptom monitoring being the only activity control
participants had been instructed to adhere to (24, 33). While
Borud et al. (33) speculated that the improvements were due
to “the therapeutic effects of research participation”, Lund
et al. (24) posited that the reductions could be attributed
to a regression toward the mean. This might be plausible
given the non-significant reductions seen in studies with
smaller sample sizes (29, 34). Although it is worth noting
that all RCTs included in this review reported some degree
of improvement within the control groups, and the majority
reported significant effects. Furthermore, data from Berin et al.’s
(29) research were excluded from the meta-analysis, as this study
reported that 35% of participants did not consistently complete
symptom diaries, suggesting reductions in VMS were likely
to be underestimated (29). However, to understand whether
this exclusion impacted the main review findings, a meta-
analysis was conducted including Berin et al.’s (29) data and it
continued to support the key result demonstrating large effects
for the prolonged use of symptom diaries on VMS frequencies
(0.61, 95% CI 0.34 to 0.88). These observations indicate that
symptom monitoring can induce clinical benefits, which authors
neither expect nor acknowledge, suggesting that there is an
unrealised potential for monitoring to be implemented as a useful
health intervention.
Further to this, in the included RCTs symptom monitoring
was not intended as an intervention and therefore do
not include non-symptom monitoring arms. Thus, it is
not possible to discern whether any observed reduction in
symptoms were an effect of symptom monitoring via diaries
or due to alternative mechanisms (e.g., passage of time),
although it would be anticipated that such mechanisms
would also be in play in any intervention group. The
MRC framework proposes that should reviewed literature
suggest an intervention has potential benefits, the next
phase to evaluate it should involve an exploratory trial (9).
Therefore, future research should explore the effects of symptom
monitoring as a standalone intervention for menopausal
symptoms against a control intervention in which monitoring
is not included. Such a design has previously been used in
fertility research, which notably demonstrated that symptom
monitoring was associated with improvements in anxiety and
depression ratings (38).
However, evidence from the reviewed studies suggest that
monitoring might be associated with increased attrition rates;
Irvin et al. (34) reported that participants allocated into the
monitoring group found symptom charting intrusive, whereas
Berin et al. (29) mentions incomplete diaries in the control
group. These factors may be indictive of negative consequences
and could have an impact on the outcomes measured; therefore,
further research should aim to understand the harms associated
with symptom monitoring, as well as the benefits.
CONCLUSIONS
This review suggests that symptom monitoring and appraisal
methods are effective for reducing menopausal symptoms, and
improving health awareness, shared decision-making, patient-
doctor communication, and treatment goal setting. In line with
the MRC framework, this suggests that symptom monitoring is
likely to be an effective intervention (9). However, these findings
are preliminary, and few studies were identified for inclusion,
many of which lacked methodological quality, suggesting more
research is needed to establish symptom monitoring as a
useful intervention. A key finding was that prolonged symptom
monitoring is effective for symptom reduction, a result which
should further be investigated via an exploratory trial, in
accordance with the methods established by the MRC framework
(9). In terms of implementing symptom monitoring within the
wider community, these results support that symptom appraisal
tools should be used in conjunction with organised health
systems to unlock potential improvements in decision-making,
goal setting, and patient-doctor communication. Ultimately,
the findings described here could provide foundational data
to researchers wishing to unravel the effects of symptom
monitoring, or develop a simple, cost-effective intervention
which may have significant implications on menopausal
health outcomes.
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